TY - JOUR
T1 - Contemporary Patterns of Multidisciplinary Care in Patients With Muscle-invasive Bladder Cancer
AU - Harshman, Lauren C.
AU - Tripathi, Abhishek
AU - Kaag, Matthew
AU - Efstathiou, Jason A.
AU - Apolo, Andrea B.
AU - Hoffman-Censits, Jean H.
AU - Stadler, Walter M.
AU - Yu, Evan Y.
AU - Bochner, Bernard H.
AU - Skinner, Eila C.
AU - Downs, Tracy
AU - Kiltie, Anne E.
AU - Bajorin, Dean F.
AU - Guru, Khurshid
AU - Shipley, William U.
AU - Steinberg, Gary D.
AU - Hahn, Noah M.
AU - Sridhar, Srikala S.
N1 - Publisher Copyright:
© 2017 Elsevier Inc.
PY - 2018/6
Y1 - 2018/6
N2 - Multidisciplinary care is crucial for the optimal treatment of patients with muscle-invasive bladder cancer. We surveyed practitioners regarding the multidisciplinary care models currently used in their practices. Most providers used some form of multidisciplinary care, with sequential clinic visits on different days the most common approach. However, most providers preferred an integrated multidisciplinary care protocol involving same-day concurrent or sequential clinic visits. Background: Multidisciplinary clinics integrate the expertise of several specialties to provide effective treatment to patients. This exposure is especially relevant in the management of muscle-invasive bladder cancer (MIBC), which requires critical input from urology, radiation oncology, and medical oncology, among other supportive specialties. Materials and Methods: In the present study, we sought to catalog the different styles of multidisciplinary care models used in the management of MIBC and to identify barriers to their implementation. We surveyed providers from academic and community practices regarding their currently implemented multidisciplinary care models, available resources, and perceived barriers using the Bladder Cancer Advocacy Network and the Genitourinary Medical Oncologists of Canada e-mail databases. Results: Of the 101 responding providers, most practiced at academic institutions in the United States (61%) or Canada (29%), and only 7% were from community practices. The most frequently used model was sequential visits on different days (57%), followed by sequential same-day (39%) and concurrent (1 visit with all providers; 22%) models. However, most practitioners preferred a multidisciplinary clinic involving sequential same-day (41%) or concurrent (26%) visits. The lack of clinic space (58%), funding (41%), staff (40%), and time (32%) were the most common barriers to implementing a multidisciplinary clinic. Conclusion: Most surveyed practitioners at academic centers use some form of a multidisciplinary care model for patients with MIBC. The major barriers to more integrated multidisciplinary clinics were limited time and resources rather than a lack of provider enthusiasm. Future studies should incorporate patient preferences, further evaluate practice patterns in community settings, and assess their effects on patient outcomes.
AB - Multidisciplinary care is crucial for the optimal treatment of patients with muscle-invasive bladder cancer. We surveyed practitioners regarding the multidisciplinary care models currently used in their practices. Most providers used some form of multidisciplinary care, with sequential clinic visits on different days the most common approach. However, most providers preferred an integrated multidisciplinary care protocol involving same-day concurrent or sequential clinic visits. Background: Multidisciplinary clinics integrate the expertise of several specialties to provide effective treatment to patients. This exposure is especially relevant in the management of muscle-invasive bladder cancer (MIBC), which requires critical input from urology, radiation oncology, and medical oncology, among other supportive specialties. Materials and Methods: In the present study, we sought to catalog the different styles of multidisciplinary care models used in the management of MIBC and to identify barriers to their implementation. We surveyed providers from academic and community practices regarding their currently implemented multidisciplinary care models, available resources, and perceived barriers using the Bladder Cancer Advocacy Network and the Genitourinary Medical Oncologists of Canada e-mail databases. Results: Of the 101 responding providers, most practiced at academic institutions in the United States (61%) or Canada (29%), and only 7% were from community practices. The most frequently used model was sequential visits on different days (57%), followed by sequential same-day (39%) and concurrent (1 visit with all providers; 22%) models. However, most practitioners preferred a multidisciplinary clinic involving sequential same-day (41%) or concurrent (26%) visits. The lack of clinic space (58%), funding (41%), staff (40%), and time (32%) were the most common barriers to implementing a multidisciplinary clinic. Conclusion: Most surveyed practitioners at academic centers use some form of a multidisciplinary care model for patients with MIBC. The major barriers to more integrated multidisciplinary clinics were limited time and resources rather than a lack of provider enthusiasm. Future studies should incorporate patient preferences, further evaluate practice patterns in community settings, and assess their effects on patient outcomes.
UR - http://www.scopus.com/inward/record.url?scp=85039157203&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85039157203&partnerID=8YFLogxK
U2 - 10.1016/j.clgc.2017.11.004
DO - 10.1016/j.clgc.2017.11.004
M3 - Article
C2 - 29289519
AN - SCOPUS:85039157203
SN - 1558-7673
VL - 16
SP - 213
EP - 218
JO - Clinical Genitourinary Cancer
JF - Clinical Genitourinary Cancer
IS - 3
ER -